Jupiter Wellness Depreciation & Amortization 2011-2026 | JUPW

Annual Depreciation & Amortization Jupiter Wellness

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
429 K	214 K	20.6 K	188 K	161 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
429 K	20.6 K	203 K

Quarterly Depreciation & Amortization Jupiter Wellness

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
147 K	-	111 K	-	102 K	-	105 K	-	-	-	4.38 K	-	72.6 K	47.2 K	25.4 K	-	71 K	44.4 K	21.6 K	-	114 K	18.2 K	20.9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
147 K	4.38 K	64.6 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	$ 21.64	-	$ 2.06 B	France
Canopy Growth Corporation CGC	21.5 M	$ 1.05	-2.34 %	$ 113 M	Canada
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.82	-1.29 %	$ 53.7 M	USA
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	125 M	$ 10.75	-2.54 %	$ 550 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Evolus EOLS	5.3 M	$ 4.28	-0.46 %	$ 265 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.69	7.78 %	$ 12 M	China
Harrow Health HROW	1.06 M	$ 47.33	-2.73 %	$ 1.54 B	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.86	-3.62 %	$ 2.14 B	Canada
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Organogenesis Holdings ORGO	13.6 M	$ 3.72	-1.2 %	$ 490 M	USA
Pacira BioSciences PCRX	78.8 M	$ 21.5	-1.08 %	$ 994 M	USA
Perrigo Company plc PRGO	326 M	$ 14.37	-1.61 %	$ 1.97 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Rockwell Medical RMTI	1.44 M	$ 1.01	-7.34 %	$ 23.6 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 3.9	-2.63 %	$ 117 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	28.2 M	$ 12.07	0.96 %	$ 857 M	USA
Tilray TLRY	35.7 M	$ 7.49	-1.77 %	$ 4.63 B	Canada
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.78	-2.46 %	$ 3.45 M	USA
Solid Biosciences SLDB	2.46 M	$ 6.15	-3.98 %	$ 251 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
SCYNEXIS SCYX	580 K	$ 0.78	-2.71 %	$ 37.3 M	USA
Veru VERU	268 K	$ 2.26	-1.74 %	$ 305 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
TherapeuticsMD TXMD	922 K	$ 2.41	-0.82 %	$ 25.2 M	USA
cbdMD YCBD	452 K	$ 0.69	-8.98 %	$ 2.98 M	USA
Viatris VTRS	3.03 B	$ 15.89	-1.48 %	$ 19.3 B	USA